Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
NVIDIA
NVDA
US Stock MarketDetailed Quotes
CLDWW CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)
- 0.006
- 0.0000.00%
15min DelayClose Dec 2 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.006Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.04052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float0.040Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM) Key Stats
EPS
According to the latest financial report of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)'s free cash flow? The latest report shows it as -4.95M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM) shows that the company's current ratio is 0.19, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the quick ratio is 0.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)? The latest ROE figure is --, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the total asset return on investment (ROA) is -77.23%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)'s latest financial report to see how their gross margin is doing - currently at 87.65%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the net profit margin is -861.48%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.